treatment, we observed an increased DNA damage response genes (gamma-H2AX, P53) and activation of apoptosis (cleaved Caspase-3 and cleaved PARP) in KE1 cell, but not in KU1919 cells. The combination of SP and cisplatin induced activation of apoptosis (cleaved Caspase-3 and cleaved PARP expression) in KU1919 cells.
INTRODUCTION AND OBJECTIVES: Circular RNAs (CircRNAs) have recently emerged as critical regulators of tumorigenesis and progression. Several studies on Cdr1as have demonstrated it to be a miRNA sponge in different tumors. However, the role of Cdr1as in bladder cancer chemosensitivity remains unclear.
METHODS: Qualitative reverse transcription polymerase chain reaction was used to detect target miRNA and gene expression in bladder cancer tissues and cell lines. The abilities of Cdr1as and its downstream regulatory molecules to induce apoptosis and promote the cisplatin chemosensitivity of bladder cancer cells were determined using flow cytometry and a cell counting kit. Bioinformatic analysis was utilized to predict potential miRNA target sites on Cdr1as. Biotincoupled miRNA capture, biotin-coupled probe pull-down assay, and RNA fluorescent in situ hybridization were performed to determine the interaction between Cdr1as and target miRNAs. Dual-luciferase reporter assay was also conducted to validate the target genes of miRNAs. The expression level of APAF1 in bladder cancer cells was identified via Western blot. Finally, the sensitivity of Cdr1as to cisplatin chemotherapy in nude mice xenografts was evaluated in terms of the size and volume of tumors.
RESULTS: Cdr1as induced the apoptosis and enhanced the cisplatin chemosensitivity of bladder cancer cells in vitro and in vivo. miR-1270 was highly expressed in bladder cancer tissues and cell lines and promoted cell proliferation, inhibited cell apoptosis, and reduced cisplatin chemosensitivity in T24 and EJ cells. Silencing of APAF1 reduced the sensitivity of bladder cancer cells to cisplatin chemotherapy. Furthermore, Cdr1as could directly sponge miR-1270 and abolish its effect on APAF1.
CONCLUSIONS: Our study verified that Cdr1as exerts a cisplatin-chemosensitization effect on bladder cancer cells through the Cdr1as/miR-1270/APAF1 axis. This newly identified axis is expected to be a potential therapeutic target for bladder cancer patients.
Source of Funding: None

MP51-18 ERa-MEDIATED ALTERATION OF CIRC_0023642 AND MIR-490-5P SIGNALING SUPPRESSES INVASION OF BLADDER CANCER
Zhenyu Ou*, Yongjie Wang, Longxiang Wu, Mengda Zhang, Long Wang, Changsha, China, People's Republic of INTRODUCTION AND OBJECTIVES: The epidemiological studies show obvious gender difference in bladder cancer (BCa): the incidence and mobility of BCa is around 4 folds higher in men than that in women. This sex disparity implies that the potential involvement of sex steroid pathways in bladder cancer development and progression. Recent researches suggest that estrogen receptor alpha (ERa) plays a protective role in BCa. However, it remains to be futher elucidated the mechanisms how ERa mediates BCa progression. As a novel class of non-coding RNAs, circular RNAs (circRNAs) could affect the development of BCa. In the present study, we tried to explore the mechanisms how ERa inhibit BCa invasion through modulating circRNAs.
METHODS: We identified 20 BCa related circRNAs through analyzing datasets and literature. Real-time PCR analysis was applied to detect the expression change of the 20 cicRNAs after manipulating ERa in BCa cell lines. In vitro invasion assay and in vivo orthotopic mouse BCa model were used to illustrate ERa affect BCa invsion and metastasis through regulating circRNA expression. Luciferase reporter assay, chromatin immunoprecipitation assay and biotin-coupled probe pull down assay were applied to dissect the mechanisms.
RESULTS: Human clinical data implied lower ERa expression might be associated with worse prognosis in BCa patients. The BCa related circRNA circ_0023642 was significantly decreased when ERa was over expressed while significantly increased when ERa was knocked down in BCa cells. In vitro invasion experiments using various BCa cells demonstrate that ERa can decrease the BCa cell invasion via suppression of circ_0023642. ERa suppressed circ_0023642 then led to increased miR-490-5p, which reduced epidermal growth factor receptor (EGFR) expression and decreased BCa cell invasion. In the orthotopic mouse BCa model, decreasing ERa with shRNA promoted BCa metastasis, while adding circ_0023642 partly reversed this effect. Further mechanism dissection showed that ERa reduced circ_002364 expression via modulating its host gene UVRAG through binding to the estrogen-response-element on the 5 0 -promoter of UVRAG. Circ_002364 was observed to directly bind to miR-490-5p. MiR-490-5p could regulate the EGFR expression via binding to the miR-490-5p binding site located on the EGFR mRNA 3 0 UTR. CONCLUSIONS: Together, these results suggest that ERa acts as a BCa suppressor by altering the ERa/ circ_0023642/miR-490-5p/ EGFR signals. This newly identified pathway may serve as basis to develop novel therapeutic strategies to treat BCa.
Source of Funding: none
MP51-19 LONG NON-CODING RNA DANCR PROMOTES MALIGNANT PHENOTYPES OF BLADDER CANCER CELLS BY MODULATING THE MIR-149 / MSI2 AXIS
Yonghao Zhan*, Zhicong Chen, Shiming He, Xuesog Li, Liqun Zhou, Beijing, China, People's Republic of INTRODUCTION AND OBJECTIVES: Accumulating evidence has indicated that long non-coding RNAs (lncRNAs) are potential biomarkers that play key roles in tumor development and progression. Differentiation antagonizing non-protein noding RNA (DANCR) is a novel lncRNA that acts as a potential biomarker and is involved in the development of cancers. Here, we elucidated the function and possible molecular mechanisms of the effect of DANCR on the biological behaviors of bladder cancer cells.
METHODS: The expression level of DANCR was determined by RT-qPCR in a total of 106 patients with urothelial bladder cancer and validated by online datasets. Loss-of-function experiments were performed to investigate the biological roles of DANCR on bladder cancer cell proliferation, migration, invasion and tumorigenicity. Comprehensive transcriptional analysis, RNA-FISH, dual-luciferase reporter assay and western blot were performed to explore the molecular mechanisms underlying the functions of DANCR.
RESULTS: DANCR was highly expressed in bladder cancer and positively correlated with advanced tumor stage and poor prognosis. Inhibition of DANCR repressed cell proliferation, migration and invasion in vitro. Moreover, inhibition of DANCR also elicited delayed tumor growth of xenograft in vivo. Mechanistically, RNA-FISH results revealed that DANCR was mainly distributed in the cytoplasm and the
